Lumenis Be Ltd.

Lumenis Be Ltd. is a global leader in energy-based medical device manufacturing, specializing in minimally invasive aesthetic and vision treatment solutions. The company develops and commercializes laser, Intense Pulsed Light (IPL), and Radio Frequency (RF) technologies for skin, body, hair, and eye care applications. With over 60 years of industry leadership, Lumenis has installed 90,000+ devices across 88+ countries and published 500+ clinical publications. Aesthetic product portfolio includes FoLix (hair loss), triLift (facial muscle stimulation), Stellar M22 (multiplatform IPL/RF), SPLENDOR X (laser hair removal), LightSheer QUATTRO (diode laser hair removal), UltraPulse Alpha (CO2 laser resurfacing), Legend Pro (Nd:YAG laser), NuEra Tight (RF body contouring), and Digital Duet (combination therapy platform). Vision product line addresses ophthalmology specialties including dry eye treatment (OptiLIGHT), glaucoma management (SLT YAG), retinal conditions, and periorbital muscle stimulation (OptiLIFT, OptiPLUS). Lumenis serves aesthetic practitioners, dermatologists, ophthalmologists, and vision care centers. The company emphasizes clinical evidence, device reliability, and practitioner education through resource hubs and training programs. Products are marketed as minimally invasive solutions for previously challenging or untreatable conditions. No specific regulatory certifications (FDA 510(k), ISO, CE mark) are explicitly stated on the homepage, though the medical device classifications and global distribution suggest compliance with applicable standards.